Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 8:44 pm Purchase | 2025-06-30 | 13G | Aditxt, Inc. ADTX | Armistice Capital, LLC | 25,823 8.700% | 25,823 (New Position) | Filing History |
| 2024-02-14 2:39 pm Sale | 2023-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP | Armistice Capital, LLC | 36,155 4.990% | -7,845 (-17.83%) | Filing History |
| 2023-02-14 11:59 am Purchase | 2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS | Armistice Capital, LLC | 2,997,111 9.990% | 2,997,111 (New Position) | Filing History |
| 2023-02-14 11:52 am Purchase | 2022-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP | Armistice Capital, LLC | 44,000 7.590% | 44,000 (New Position) | Filing History |
| 2021-07-06 4:21 pm Purchase | 2021-06-23 | 13D | Acurx Pharmaceuticals, Inc. ACXP | LUCI DAVID P | 67,555 13.200% | 67,555 (New Position) | Filing History |
| 2021-07-06 4:20 pm Purchase | 2021-06-23 | 13D | Acurx Pharmaceuticals, Inc. ACXP | DELUCCIA ROBERT J | 66,389 13.000% | 66,389 (New Position) | Filing History |